Newsletter Archive

PEP News

LPEP Novartis

Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

2 November, 2020 | Novartis International AG

Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

Read Article >

Project to End Child Leprosy Among Top 100 Proposals for MacArthur $100 Million Grant

26 February, 2020 | Global Partnership for Zero Leprosy

The John D. and Catherine T. MacArthur Foundation announced today that ‘End Child Leprosy by 2030: Break Transmission and Eliminate Stigma’ was one of the highest-scoring proposals, designated as the Top 100, in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical social challenges.

Read Article >

Guidelines for the diagnosis, treatment and prevention of leprosy

20 August, 2018 | World Health Organization

WHO’s Global Leprosy Programme has released the full Guidelines for the diagnosis, treatment and prevention of leprosy. The Guidelines provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in low and middle-income countries. … More Guidelines for the diagnosis, treatment and prevention of leprosy

Go to Article >